|
- Home - Sana Biotechnology
Sana is creating engineered cells to repair and control genes in cells or replace missing or damaged cells to solve the underlying causes of disease
- Our Science - Sana Biotechnology
Sana’s in vivo Cell Engineering platform aims to provide solutions for patients that current gene therapies cannot address Success will require creative science, experienced product and clinical development strategies, and aggregating important technologies
- Our Pipeline - Sana Biotechnology
Sana is committed to developing safe and effective engineered cells as medicines, which involves evaluation in clinical trials followed by submission of the trial results to regulatory agencies, such as the U S Food and Drug Administration (FDA)
- Our Story - Sana Biotechnology
Sana was founded with the long view – bringing together great people and the best technologies to deliver on the challenging promise of engineered cells as medicines Three aspirations drive Sana as we look to treat patients with poor outcomes or currently untreatable diseases
- For Patients - Sana Biotechnology
Sana is a science-driven, patient-centric company filled with employees who wake up everyday focused on advancing potentially curative medicines for people in need
- News Releases - Sana Biotechnology, Inc
SEATTLE, Aug 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in September
- News - Sana Biotechnology
Explore news and announcements from Sana Biotechnology to learn more about progress in engineering cells to be medicines
- Contact Us - Sana Biotechnology
We'd love to hear from you Reach out to learn more about how Sana is working to deliver on the promise of engineering cells to be medicines
|
|
|